Literature DB >> 20064650

GAG-binding variants of tick-borne encephalitis virus.

L I Kozlovskaya1, D I Osolodkin, A S Shevtsova, L Iu Romanova, Y V Rogova, T I Dzhivanian, V N Lyapustin, G P Pivanova, A P Gmyl, V A Palyulin, G G Karganova.   

Abstract

Previously different authors described various flavivirus mutants with high affinity to cell glycosaminoglycans and low neuroinvasiveness in mice that were obtained consequently passages in cell cultures or in ticks. In present study the analysis of TBEV isolates has shown existence of GAG-binding variants in natural virus population. Affinity to GAG has been evaluated by sorption on heparin-Sepharose. GAG-binding phenotype corresponds to such virus properties, like small plaque phenotype in PEK cells, absence of hemagglutination at pH 6.4, and low neuroinvasiveness in mice. Mutations increasing charge of E protein were necessary but not sufficient for acquisition of GAG-binding phenotype. Molecular modeling and molecular dynamics simulation have shown that the flexibility of E protein molecule could bear influence on the phenotypic manifestation of substitutions increasing charge of the virions. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20064650     DOI: 10.1016/j.virol.2009.12.012

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Tick-borne encephalitis virus: reference strain Sofjin and problem of its authenticity.

Authors:  S Y Kovalev; T A Mukhacheva; V S Kokorev; I V Belyaeva
Journal:  Virus Genes       Date:  2011-11-18       Impact factor: 2.332

2.  Mutations present in a low-passage Zika virus isolate result in attenuated pathogenesis in mice.

Authors:  Nisha K Duggal; Erin M McDonald; James Weger-Lucarelli; Seth A Hawks; Jana M Ritter; Hannah Romo; Gregory D Ebel; Aaron C Brault
Journal:  Virology       Date:  2019-02-07       Impact factor: 3.616

3.  Basic Amino Acid Substitution at Residue 367 of the Envelope Protein of Tembusu Virus Plays a Critical Role in Pathogenesis.

Authors:  Mengxu Sun; Lijiao Zhang; Yanxin Cao; Jun Wang; Ziding Yu; Xue Sun; Fengli Liu; Zhuolin Li; Pinghuang Liu; Jingliang Su
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

Review 4.  Molecular mechanisms involved in the early steps of flavivirus cell entry.

Authors:  Bärbel Kaufmann; Michael G Rossmann
Journal:  Microbes Infect       Date:  2010-12-10       Impact factor: 2.700

5.  Carbohydrate force fields.

Authors:  B Lachele Foley; Matthew B Tessier; Robert J Woods
Journal:  Wiley Interdiscip Rev Comput Mol Sci       Date:  2012-07

6.  A critical determinant of neurological disease associated with highly pathogenic tick-borne flavivirus in mice.

Authors:  Kentaro Yoshii; Yuji Sunden; Kana Yokozawa; Manabu Igarashi; Hiroaki Kariwa; Michael R Holbrook; Ikuo Takashima
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

Review 7.  Flavivirus cell entry and membrane fusion.

Authors:  Jolanda M Smit; Bastiaan Moesker; Izabela Rodenhuis-Zybert; Jan Wilschut
Journal:  Viruses       Date:  2011-02-22       Impact factor: 5.818

8.  Genetic description of a tick-borne encephalitis virus strain Sofjin with the longest history as a vaccine strain.

Authors:  M F Vorovitch; L I Kozlovskaya; L Iu Romanova; L L Chernokhaeva; A A Ishmukhametov; G G Karganova
Journal:  Springerplus       Date:  2015-12-09

9.  Exploring of primate models of tick-borne flaviviruses infection for evaluation of vaccines and drugs efficacy.

Authors:  Natalia S Pripuzova; Larissa V Gmyl; Lidiya Iu Romanova; Natalia V Tereshkina; Yulia V Rogova; Liubov L Terekhina; Liubov I Kozlovskaya; Mikhail F Vorovitch; Karina G Grishina; Andrey V Timofeev; Galina G Karganova
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

10.  Tick-borne encephalitis virus infects rat astrocytes but does not affect their viability.

Authors:  Maja Potokar; Miša Korva; Jernej Jorgačevski; Tatjana Avšič-Županc; Robert Zorec
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.